The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Review on Korean Medicine and Personalized Medicine: Syndrome-based Personalized Medicine on the Basis of Syndrome Differentiation and Treatment

한의학과 개인맞춤의학에 대한 소고; 변증논치에 근거한 '증 기반 개인맞춤의학'

  • Han, Jae Min (Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University) ;
  • Yang, Woong Mo (Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University)
  • 한재민 (경희대학교 한의과대학 융합한의과학교실) ;
  • 양웅모 (경희대학교 한의과대학 융합한의과학교실)
  • Received : 2014.05.19
  • Accepted : 2014.07.16
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to review the characteristics of personalized medicine and Korean medicine, and the correlation between personalized medicine and Korean medicine. Methods: We investigated various studies in PubMed, Scopus and domestic Korean medicine journals. In addition, we discussed the topic based on literature. Results: Western medicine developed as evidence-based medicine. However, its limitations are being reached, so a new paradigm of medicine is needed. As a result, personalized medicine has appeared. Recently, through the development of human genomics, personalized medicine has been researched on the basis of individual genetic characteristics. Korean medicine has developed with a unique holistic approach and treats not the disease itself but the patient's body. Its characteristic is well expressed through syndrome differentiation and treatment. Syndrome differentiation represents the nature of person-centered medicine and becomes the root of personalized medicine. Conclusions: Compared with genome-based personalized medicine of Western medicine, Korean medicine could be classified as syndrome-based personalized medicine. It would be great to apply this characteristic to clinical practices.

Keywords

References

  1. Ahn HS. Introduction to Evidence-based Medicine. Journal of Korean Society of Quality Assurance in Health Care. 2005;12(2):9-16.
  2. Lim YC. A Critical Contemplation on 'Personalized Medicine' of Modern Medicine. The Korean Association for Philosophy of Medicine. 2012; 13:135-162.
  3. Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB Rep. 2010;43(10):643648.
  4. Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
  5. Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, et al. Clinical Pharmacogenetics and Potential Application in Personalized Medicine. Curr Drug Metab. 2008;9(8):738-84. https://doi.org/10.2174/138920008786049302
  6. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010; 363(4):301-4. https://doi.org/10.1056/NEJMp1006304
  7. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature. 2009; 461(7265):724-6. https://doi.org/10.1038/461724a
  8. Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2): 188-91. https://doi.org/10.1038/gene.2008.99
  9. Dai J, Fang J, Sun S, Chen Q, Cao H, Zheng N, et al. ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine. Evid Based Complement Alternat Med. 2013;2013:235969.
  10. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992; 268(17):2420-5. https://doi.org/10.1001/jama.1992.03490170092032
  11. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023):71-2. https://doi.org/10.1136/bmj.312.7023.71
  12. Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ. 1995;310(6987):1122-6. https://doi.org/10.1136/bmj.310.6987.1122
  13. Tonelli MR. The philosophical limits of evidence-based medicine. Acad Med. 1998; 73(12):1234-40. https://doi.org/10.1097/00001888-199812000-00011
  14. Goldman JJ, Shih TL. The limitations of evidence-based medicine--applying population-based recommendations to individual patients. Virtual Mentor. 2011;13(1):26-30. https://doi.org/10.1001/virtualmentor.2011.13.1.jdsc1-1101
  15. Jain KK. Textbook of Personalized Medicine. New York:Springer. 2009:1-136.
  16. Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ. 2000 Oct 3;163(7):837-41.
  17. Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of Evidence-Based Medicine. Int J Med Inform. 2004;73(1):35-43. https://doi.org/10.1016/j.ijmedinf.2003.11.002
  18. Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19(12): 491-6. https://doi.org/10.1016/S0167-7799(01)01814-5
  19. Ray O. The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness. Ann N Y Acad Sci. 2004;1032:35-51. https://doi.org/10.1196/annals.1314.004
  20. Yan Q. Toward the integration of personalized and systems medicine: challenges, opportunities and approaches. Personalized Medicine. 2011; 8(1):1-4. https://doi.org/10.2217/pme.10.77
  21. Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, et al. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992-8. https://doi.org/10.1592/phco.28.8.992
  22. Novelli G. Personalized genomic medicine. Intern Emerg Med. 2010;5(1):81-90.
  23. Lee SW, Lee KB, Kang JW, Choi JH, Oh JH. Trends in Personalized Medicine Research, Communications of the Korean Institute of Information Scientists and Engineer. 2011;29(4): 19-25.
  24. Emilien G, Ponchon M, Caldas C, Isacson O, Maloteaux JM. Impact of genomics on drug discovery and clinical medicine. QJM. 2000; 93(7):391-423. https://doi.org/10.1093/qjmed/93.7.391
  25. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-78. https://doi.org/10.1038/nature05911
  26. Gispen WH, Adan RAH. Preface. Eur J Pharmacol. 2000;410(2-3):105. https://doi.org/10.1016/S0014-2999(00)00808-6
  27. Shin JG, Cha IJ. Pharmacogenetics: A Principle for the Personalized Pharmacotherapy. Inje Medical Journal. 2002;23(2):71-83.
  28. Yan Q. Pharmacogenomics in Drug Discovery and Development : From Bench to Bedside. Clifton:Methods Mol Biol. 2008;448:5-7.
  29. Zhang A, Sun H, Wang P, Han Y, Wang X. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med. 2012;20(1-2): 93-9. https://doi.org/10.1016/j.ctim.2011.10.007
  30. Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal. 2011;55(5):859-68. https://doi.org/10.1016/j.jpba.2011.01.042
  31. Kim WH. Hanuihak Wonron. Seoul:Seongbosa. 2001:32-34.
  32. Lesko LJ. Personalized medicine: elusive dream or imminent reality?. Clin Pharmacol Ther. 2007;81(6):807-16. https://doi.org/10.1038/sj.clpt.6100204
  33. Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics. 2013;14:55. https://doi.org/10.1186/1472-6939-14-55
  34. Franzel B, Schwiegershausen M, Heusser P, Berger B. Individualised medicine from the perspectives of patients using complementary therapies: a meta-ethnography approach. BMC Complement Altern Med. 2013;13:124. https://doi.org/10.1186/1472-6882-13-124

Cited by

  1. 중국 네트워크약리학 데이터베이스 구축 현황 및 TCMSP의 활용가능성 검토 - 사상체질의학의 약물을 중심으로 - vol.29, pp.6, 2014, https://doi.org/10.15188/kjopp.2015.12.12.29.6.443
  2. 비허형 아토피 동물모델 개발 vol.31, pp.4, 2014, https://doi.org/10.15188/kjopp.2017.08.31.4.213
  3. 방약합편과 한의학 임상표현 vol.40, pp.1, 2014, https://doi.org/10.13048/jkm.19001
  4. 건선의 동서의학적 연구 특징의 비교 vol.42, pp.2, 2014, https://doi.org/10.13048/jkm.21016